FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095778841> ?p ?o ?g. }

• W2095778841 endingPage "161" @default.
• W2095778841 startingPage "153" @default.
• W2095778841 abstract "The tumor necrosis factor (TNF) receptor super family comprises of members that induce two distinct signaling cascades, leading to either cell survival or apoptosis. However, in prostate cancer (PCa), TNF-mediated prosurvival signaling is the predominant pathway that leads to cell survival and resistance to therapy. Although inhibition of TNF signaling by pharmacological agents or monoclonal antibodies has gained importance in the field of cancer therapy, toxicity to normal cells has impaired their extensive use for cancer treatment. We previously identified a natural, nontoxic compound psoralidin that inhibited viability and induced apoptosis in androgen independent prostate cancer (AIPC) cells. Thus, the goal of our study is to investigate whether psoralidin inhibits TNF-mediated prosurvival signaling in AIPC cells. Our results suggest that psoralidin inhibits constitutive and TNF-induced expression of TNF-α and its downstream prosurvival signaling molecules such as NF-κB and Bcl-2 in AIPC cells. On the other hand, psoralidin simultaneously induces the death receptor (DR)-mediated apoptotic signaling eventually causing the activation of caspase cascade and resultant induction of apoptosis. Oral administration of psoralidin inhibits expression of TNF-α and NF-κB/p65 in tumor sections, resulting in tumor regression in PC-3 xenografts. Our results suggest that psoralidin inhibits TNF-mediated survival signaling in AIPC and thus is a potent therapeutic agent for prostate cancer." @default.
• W2095778841 created "2016-06-24" @default.
• W2095778841 creator A5040331430 @default.
• W2095778841 creator A5043034833 @default.
• W2095778841 creator A5065143008 @default.
• W2095778841 creator A5072425635 @default.
• W2095778841 creator A5077759533 @default.
• W2095778841 date "2009-10-23" @default.
• W2095778841 modified "2023-10-16" @default.
• W2095778841 title "Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer" @default.
• W2095778841 cites W1492587973 @default.
• W2095778841 cites W1532384917 @default.
• W2095778841 cites W1560704839 @default.
• W2095778841 cites W1807380980 @default.
• W2095778841 cites W1965814380 @default.
• W2095778841 cites W1967912613 @default.
• W2095778841 cites W1986978728 @default.
• W2095778841 cites W1989632462 @default.
• W2095778841 cites W1997106678 @default.
• W2095778841 cites W2001562768 @default.
• W2095778841 cites W2001627013 @default.
• W2095778841 cites W2005992345 @default.
• W2095778841 cites W2023485283 @default.
• W2095778841 cites W2031554805 @default.
• W2095778841 cites W2036453394 @default.
• W2095778841 cites W2038259382 @default.
• W2095778841 cites W2041466047 @default.
• W2095778841 cites W2049601585 @default.
• W2095778841 cites W2065317589 @default.
• W2095778841 cites W207000493 @default.
• W2095778841 cites W2078960019 @default.
• W2095778841 cites W2101174594 @default.
• W2095778841 cites W2113641491 @default.
• W2095778841 cites W2118936797 @default.
• W2095778841 cites W2121391223 @default.
• W2095778841 cites W2144116189 @default.
• W2095778841 cites W2145662662 @default.
• W2095778841 cites W2148894303 @default.
• W2095778841 cites W2152687551 @default.
• W2095778841 cites W2154951555 @default.
• W2095778841 cites W2155098516 @default.
• W2095778841 cites W2157999078 @default.
• W2095778841 cites W2169765850 @default.
• W2095778841 doi "https://doi.org/10.1007/s10495-009-0416-9" @default.
• W2095778841 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2813934" @default.
• W2095778841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19851870" @default.
• W2095778841 hasPublicationYear "2009" @default.
• W2095778841 type Work @default.
• W2095778841 sameAs 2095778841 @default.
• W2095778841 citedByCount "38" @default.
• W2095778841 countsByYear W20957788412012 @default.
• W2095778841 countsByYear W20957788412013 @default.
• W2095778841 countsByYear W20957788412014 @default.
• W2095778841 countsByYear W20957788412015 @default.
• W2095778841 countsByYear W20957788412016 @default.
• W2095778841 countsByYear W20957788412017 @default.
• W2095778841 countsByYear W20957788412018 @default.
• W2095778841 countsByYear W20957788412019 @default.
• W2095778841 countsByYear W20957788412020 @default.
• W2095778841 countsByYear W20957788412021 @default.
• W2095778841 countsByYear W20957788412022 @default.
• W2095778841 countsByYear W20957788412023 @default.
• W2095778841 crossrefType "journal-article" @default.
• W2095778841 hasAuthorship W2095778841A5040331430 @default.
• W2095778841 hasAuthorship W2095778841A5043034833 @default.
• W2095778841 hasAuthorship W2095778841A5065143008 @default.
• W2095778841 hasAuthorship W2095778841A5072425635 @default.
• W2095778841 hasAuthorship W2095778841A5077759533 @default.
• W2095778841 hasBestOaLocation W20957788412 @default.
• W2095778841 hasConcept C121608353 @default.
• W2095778841 hasConcept C126322002 @default.
• W2095778841 hasConcept C17991360 @default.
• W2095778841 hasConcept C190283241 @default.
• W2095778841 hasConcept C203014093 @default.
• W2095778841 hasConcept C2780192828 @default.
• W2095778841 hasConcept C31573885 @default.
• W2095778841 hasConcept C502942594 @default.
• W2095778841 hasConcept C55493867 @default.
• W2095778841 hasConcept C62478195 @default.
• W2095778841 hasConcept C71924100 @default.
• W2095778841 hasConcept C86803240 @default.
• W2095778841 hasConcept C95444343 @default.
• W2095778841 hasConcept C96232424 @default.
• W2095778841 hasConcept C98274493 @default.
• W2095778841 hasConceptScore W2095778841C121608353 @default.
• W2095778841 hasConceptScore W2095778841C126322002 @default.
• W2095778841 hasConceptScore W2095778841C17991360 @default.
• W2095778841 hasConceptScore W2095778841C190283241 @default.
• W2095778841 hasConceptScore W2095778841C203014093 @default.
• W2095778841 hasConceptScore W2095778841C2780192828 @default.
• W2095778841 hasConceptScore W2095778841C31573885 @default.
• W2095778841 hasConceptScore W2095778841C502942594 @default.
• W2095778841 hasConceptScore W2095778841C55493867 @default.
• W2095778841 hasConceptScore W2095778841C62478195 @default.
• W2095778841 hasConceptScore W2095778841C71924100 @default.
• W2095778841 hasConceptScore W2095778841C86803240 @default.
• W2095778841 hasConceptScore W2095778841C95444343 @default.
• W2095778841 hasConceptScore W2095778841C96232424 @default.

• next